Ethanol extract of the tuber of Alisma orientale reduces the pathologic features in a chronic obstructive pulmonary disease mouse model

J Ethnopharmacol. 2016 Jul 21:188:21-30. doi: 10.1016/j.jep.2016.05.004. Epub 2016 May 3.

Abstract

Ethnopharmacological relevance: The tuber of Alismataceae Alisma orientale Juzepzuk has been prescribed as a remedy for treating the diseases associated with body fluid dysfunction such as edema and inflammatory lung diseases. Chronic obstructive pulmonary disease (COPD) is a debilitating, inflammatory lung disease without effective treatment. Along with persistent inflammation, autophagy has been recently reported to contribute to COPD. Here, by employing a murine model, we examined whether the tuber of the plant is effective against COPD MATERIALS AND METHODS: The ethanol extract of the tuber of A. orientale Juzepzuk (EEAO) was fingerprinted by HPLC. For the establishment of COPD lung, mice received single intratracheal (i.t.) spraying of elastase and LPS per week for 2 weeks. After approximated to the dose prescribed typically to patients, EEAO was administered to the lung 2h after each LPS treatment. Morphometric analyses, semi-quantitative RT-PCR, and western blot were performed to evaluate the effects of EEAO on emphysema, inflammation, and autophagy in mouse lungs. The effect of EEAO on autophagy was also assessed by western blot at the cellular level with murine macrophages and human lung epithelial cells.

Results: When receiving i.t. elastase and LPS for 2 weeks, mice developed emphysema and inflammation in the lung. EEAO treatment, however, significantly reduced emphysema and inflammatory cell infiltration to the lung with concomitant decrease of the production of pro-inflammatory cytokines including TNF-α, IL-6, and TGF-β, signature cytokines of COPD. Unlike control mice, the lungs of the COPD mice expressed LC3-II, a biomarker for autophagy formation, which was decreased by EEAO treatment. EEAO also lowered the expression of LC3-II in murine macrophage, RAW 264.7, and human lung epithelial cell, BEAS-2B, which was associated with EEAO activating mTOR.

Conclusion: EEAO relieved COPD pathologic features in a mouse model, which was associated with suppression of lung inflammation, emphysema, and autophagy. Our results suggest an effectiveness of the tuber of A. orientale in chronic inflammatory lung diseases such as COPD.

Keywords: Alismataceae Alisma Orientale Juzepzuk; Animal model; Autophagy; Chronic obstructive pulmonary disease; Emphysema; Inflammation.

MeSH terms

  • Alisma / chemistry*
  • Animals
  • Anti-Inflammatory Agents / isolation & purification
  • Anti-Inflammatory Agents / pharmacology*
  • Autophagy / drug effects
  • Chromatography, High Pressure Liquid
  • Cytokines / genetics
  • Cytokines / metabolism
  • Disease Models, Animal
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism
  • Epithelial Cells / pathology
  • Ethanol / chemistry*
  • Humans
  • Inflammation Mediators / metabolism
  • Lipopolysaccharides
  • Lung / drug effects*
  • Lung / metabolism
  • Lung / pathology
  • Macrophages / drug effects
  • Macrophages / metabolism
  • Macrophages / pathology
  • Magnetic Resonance Spectroscopy
  • Mass Spectrometry
  • Mice
  • Mice, Inbred C57BL
  • Microtubule-Associated Proteins / metabolism
  • Pancreatic Elastase
  • Plant Extracts / isolation & purification
  • Plant Extracts / pharmacology*
  • Plant Tubers / chemistry*
  • Pneumonia / chemically induced
  • Pneumonia / metabolism
  • Pneumonia / pathology
  • Pneumonia / prevention & control*
  • Pulmonary Disease, Chronic Obstructive / chemically induced
  • Pulmonary Disease, Chronic Obstructive / metabolism
  • Pulmonary Disease, Chronic Obstructive / pathology
  • Pulmonary Disease, Chronic Obstructive / prevention & control*
  • Pulmonary Emphysema / chemically induced
  • Pulmonary Emphysema / metabolism
  • Pulmonary Emphysema / pathology
  • Pulmonary Emphysema / prevention & control*
  • RAW 264.7 Cells
  • Signal Transduction / drug effects
  • Solvents / chemistry*
  • TOR Serine-Threonine Kinases / metabolism
  • Transforming Growth Factor beta / genetics
  • Transforming Growth Factor beta / metabolism

Substances

  • Anti-Inflammatory Agents
  • Cytokines
  • Inflammation Mediators
  • Lipopolysaccharides
  • Map1lc3b protein, mouse
  • Microtubule-Associated Proteins
  • Plant Extracts
  • Solvents
  • Transforming Growth Factor beta
  • Ethanol
  • mTOR protein, mouse
  • TOR Serine-Threonine Kinases
  • Pancreatic Elastase